As Stx-B binding was similar between the control and STEC-HUS BOECs, we investigated if this also resulted in similar cytotoxicity levels for Stx2a tested with a 3H-leucine protein synthesis assay. The gene discussed is STX2; the disease is hemolytic-uremic syndrome.